{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T17:41:34Z","timestamp":1781804494468,"version":"3.54.5"},"reference-count":70,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.urolonc.2021.04.042","type":"journal-article","created":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T03:20:02Z","timestamp":1622776802000},"page":"512-524","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["A contemporary guide to chromosomal copy number profiling in the diagnosis of renal cell carcinoma"],"prefix":"10.1016","volume":"40","author":[{"given":"Sounak","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Sukov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad M.","family":"Vanderbilt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loren","family":"Herrera-Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M.","family":"Lohse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Houston","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen A.","family":"Boorjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley C.","family":"Leibovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael E.","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Cheville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2021.04.042_bib0001","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nature12222","article-title":"Comprehensive molecular characterization of clear cell renal cell carcinoma","volume":"499","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0002","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1056\/NEJMoa1505917","article-title":"Comprehensive molecular characterization of papillary renal-cell carcinoma","volume":"374","author":"Linehan","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0003","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ccr.2014.07.014","article-title":"The somatic genomic landscape of chromophobe renal cell carcinoma","volume":"26","author":"Davis","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0004","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.celrep.2018.03.075","article-title":"The cancer genome atlas comprehensive molecular characterization of renal cell carcinoma","volume":"23","author":"Ricketts","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0005","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.humpath.2019.08.005","article-title":"Diagnosis of uncommon renal epithelial neoplasms: performances of fluorescence in situ hybridization","volume":"92","author":"Beaumont","year":"2019","journal-title":"Hum Pathol"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41241-016-0007-3","article-title":"Utilization of the oncoscan microarray assay in cancer diagnostics","volume":"37","author":"Jung","year":"2017","journal-title":"Applied Cancer Research"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0007","doi-asserted-by":"crossref","first-page":"494","DOI":"10.5858\/arpa.2018-0104-OA","article-title":"Clinical utility of chromosome genomic array testing for unclassified and advanced-stage renal cell carcinomas","volume":"143","author":"Andeen","year":"2019","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0008","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.cancergen.2020.04.004","article-title":"Assessing genomic copy number alterations as best practice for renal cell neoplasia: an evidence-based review from the cancer genomics consortium workgroup","volume":"244","author":"Liu","year":"2020","journal-title":"Cancer Genet"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0009","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jmoldx.2016.09.010","article-title":"Next-generation assessment of human epidermal growth factor receptor 2 (erbb2) amplification status: clinical validation in the context of a hybrid capture-based, comprehensive solid tumor genomic profiling assay","volume":"19","author":"Ross","year":"2017","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0010","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1093\/nar\/gkw520","article-title":"FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing","volume":"44","author":"Shen","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0011","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1016\/j.celrep.2018.06.032","article-title":"The cancer genome atlas comprehensive molecular characterization of renal cell carcinoma","volume":"23","author":"Ricketts","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0012","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.cell.2018.02.020","article-title":"Timing the landmark events in the evolution of clear cell renal cell cancer: TRACERx renal","volume":"173","author":"Mitchell","year":"2018","journal-title":"Cell."},{"key":"10.1016\/j.urolonc.2021.04.042_bib0013","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/modpathol.2015.6","article-title":"TCEB1-mutated renal cell carcinoma: a distinct genomic and morphological subtype","volume":"28","author":"Hakimi","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0014","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/PAS.0000000000001422","article-title":"\"Renal cell carcinoma with leiomyomatous stroma\" harbor somatic mutations of TSC1, TSC2, MTOR, and\/or ELOC (TCEB1): clinicopathologic and molecular characterization of 18 sporadic tumors supports a distinct entity","volume":"44","author":"Shah","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0015","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.ccr.2013.10.025","article-title":"SQSTM1 is a pathogenic target of 5q copy number gains in kidney cancer","volume":"24","author":"Li","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0016","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/cncr.27947","article-title":"Deletions of chromosomes 3p and 14q molecularly subclassify clear cell renal cell carcinoma","volume":"119","author":"Kroeger","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0017","doi-asserted-by":"crossref","first-page":"e38986","DOI":"10.7554\/eLife.38986","article-title":"Abnormal oxidative metabolism in a quiet genomic background underlies clear cell papillary renal cell carcinoma","volume":"8","author":"Xu","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0018","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.humpath.2019.05.011","article-title":"Clear cell papillary renal cell carcinoma: molecular profile and virtual karyotype","volume":"91","author":"Morlote","year":"2019","journal-title":"Hum Pathol"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0019","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.pathol.2020.10.002","article-title":"Clear cell papillary renal cell carcinoma: an update after 15 years","volume":"53","author":"Williamson","year":"2021","journal-title":"Pathology"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0020","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/his.14071","article-title":"Defining clear cell papillary renal cell carcinoma in routine clinical practice","volume":"76","author":"Gupta","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0021","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.eururo.2020.03.003","article-title":"Next-generation RNA sequencing-based biomarker characterization of chromophobe renal cell carcinoma and related oncocytic neoplasms","volume":"78","author":"Skala","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0022","article-title":"Cytogenetic analysis of 130 renal oncocytomas identify three distinct and mutually exclusive diagnostic classes of chromosome aberrations","author":"Anderson","year":"2019","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0023","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.humpath.2009.01.016","article-title":"CCND1 rearrangements and cyclin D1 overexpression in renal oncocytomas: frequency, clinicopathologic features, and utility in differentiation from chromophobe renal cell carcinoma","volume":"40","author":"Sukov","year":"2009","journal-title":"Hum Pathol"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0024","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/PAP.0000000000000286","article-title":"Comprehensive review of numerical chromosomal aberrations in chromophobe renal cell carcinoma including its variant morphologies","volume":"28","author":"Alaghehbandan","year":"2021","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0025","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.humpath.2020.07.003","article-title":"Sporadic oncocytic tumors with features intermediate between oncocytoma and chromophobe renal cell carcinoma: comprehensive clinicopathological and genomic profiling","volume":"104","author":"Liu","year":"2020","journal-title":"Hum Pathol"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0026","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1038\/s41379-019-0304-y","article-title":"Hybrid oncocytic\/chromophobe renal tumors are molecularly distinct from oncocytoma and chromophobe renal cell carcinoma","volume":"32","author":"Ruiz-Cordero","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0027","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/modpathol.3800286","article-title":"Eosinophilic and classic chromophobe renal cell carcinomas have similar frequent losses of multiple chromosomes from among chromosomes 1, 2, 6, 10, and 17, and this pattern of genetic abnormality is not present in renal oncocytoma","volume":"18","author":"Brunelli","year":"2005","journal-title":"Mod Pathol"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0028","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.3390\/cancers11101492","article-title":"Classic chromophobe renal cell carcinoma incur a larger number of chromosomal losses than seen in the eosinophilic subtype","volume":"11","author":"Ohashi","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0029","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00428-018-2389-y","article-title":"Cytogenetic and immunohistochemical study of 42 pigmented microcystic chromophobe renal cell carcinoma (PMChRCC)","volume":"473","author":"Gutierrez","year":"2018","journal-title":"Virchows Arch"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0030","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00428-004-1187-x","article-title":"Chromophobe renal cell carcinoma with microcystic and adenomatous arrangement and pigmentation\u2013a diagnostic pitfall. Morphological, immunohistochemical, ultrastructural and molecular genetic report of 20 cases","volume":"446","author":"Hes","year":"2005","journal-title":"Virchows Arch"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0031","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00428-016-2022-x","article-title":"Morphological, immunohistochemical, and chromosomal analysis of multicystic chromophobe renal cell carcinoma, an architecturally unusual challenging variant","volume":"469","author":"Foix","year":"2016","journal-title":"Virchows Arch"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0032","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.anndiagpath.2015.05.001","article-title":"Chromophobe renal cell carcinoma with neuroendocrine and neuroendocrine-like features. Morphologic, immunohistochemical, ultrastructural, and array comparative genomic hybridization analysis of 18 cases and review of the literature","volume":"19","author":"Peckova","year":"2015","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0033","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/PAS.0000000000001038","article-title":"Distinct genomic copy number alterations distinguish mucinous tubular and spindle cell carcinoma of the kidney from papillary renal cell carcinoma with overlapping histologic features","volume":"42","author":"Ren","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0034","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/s41379-020-00667-9","article-title":"Adverse histology, homozygous loss of CDKN2A\/B, and complex genomic alterations in locally advanced\/metastatic renal mucinous tubular and spindle cell carcinoma","volume":"34","author":"Yang","year":"2021","journal-title":"Mod Pathol"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0035","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1097\/01.MP.0000031709.40712.46","article-title":"Low-grade tubular-mucinous renal neoplasms: morphologic, immunohistochemical, and genetic features","volume":"15","author":"Rakozy","year":"2002","journal-title":"Mod Pathol"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0036","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1007\/s00428-005-0036-x","article-title":"Mucinous tubular and spindle cell carcinoma: a report of 15 cases and a review of the literature","volume":"447","author":"Ferlicot","year":"2005","journal-title":"Virchows Arch"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0037","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/modpathol.3800499","article-title":"Genomic aberrations in mucinous tubular and spindle cell renal cell carcinomas","volume":"19","author":"Brandal","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0038","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00292-003-0657-2","article-title":"[Mucinous spindle cell carcinoma of the kidney. A molecular analysis]","volume":"24","author":"Weber","year":"2003","journal-title":"Pathologe"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0039","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1097\/PAS.0000000000001150","article-title":"VSTM2A overexpression is a sensitive and specific biomarker for mucinous tubular and spindle cell carcinoma (MTSCC) of the kidney","volume":"42","author":"Wang","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0040","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1097\/PAS.0000000000001307","article-title":"TFEB expression profiling in renal cell carcinomas: clinicopathologic correlations","volume":"43","author":"Gupta","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0041","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.eururo.2018.06.007","article-title":"Somatic Bi-allelic loss of TSC genes in eosinophilic solid and cystic renal cell carcinoma","volume":"74","author":"Mehra","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.mayocp.2020.11.004","article-title":"Renal neoplasia in tuberous sclerosis: a study of 41 patients","author":"Gupta","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0043","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1164\/ajrccm.164.8.2104095","article-title":"Chromosome 16 loss of heterozygosity in tuberous sclerosis and sporadic lymphangiomyomatosis","volume":"164","author":"Yu","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0044","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/modpathol.2010.114","article-title":"Loss of heterozygosity on tuberous sclerosis complex genes in multifocal micronodular pneumocyte hyperplasia","volume":"23","author":"Hayashi","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0045","doi-asserted-by":"crossref","first-page":"15816","DOI":"10.1038\/ncomms15816","article-title":"The genomic landscape of tuberous sclerosis complex","volume":"8","author":"Martin","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0046","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1097\/PAS.0000000000000838","article-title":"Eosinophilic solid and cystic renal cell carcinoma (ESC RCC): further morphologic and molecular characterization of ESC RCC as a distinct entity","volume":"41","author":"Trpkov","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0047","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1016\/j.juro.2013.06.012","article-title":"Germline PTEN mutation Cowden syndrome: an underappreciated form of hereditary kidney cancer","volume":"190","author":"Shuch","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0048","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1016\/j.mayocp.2020.09.016","article-title":"Renal neoplasia in Cowden syndrome","volume":"95","author":"Gupta","year":"2020","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0049","doi-asserted-by":"crossref","first-page":"6686","DOI":"10.1158\/1078-0432.CCR-17-1057","article-title":"Sarcomatoid renal cell carcinoma has a distinct molecular pathogenesis, driver mutation profile, and transcriptional landscape","volume":"23","author":"Wang","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0050","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/s41585-020-00382-9","article-title":"Sarcomatoid renal cell carcinoma: biology, natural history and management","volume":"17","author":"Blum","year":"2020","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0051","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1158\/1078-0432.CCR-20-2063","article-title":"Efficacy and safety of nivolumab plus ipilimumab versus sunitinib in first-line treatment of patients with advanced sarcomatoid renal cell carcinoma","volume":"27","author":"Tannir","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0052","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1158\/2326-6066.CIR-15-0150","article-title":"PD-1 and PD-L1 expression in renal cell carcinoma with sarcomatoid differentiation","volume":"3","author":"Joseph","year":"2015","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0053","doi-asserted-by":"crossref","first-page":"4823","DOI":"10.1002\/cncr.30937","article-title":"Programmed cell death ligand 1 and tumor-infiltrating lymphocyte status in patients with renal cell carcinoma and sarcomatoid dedifferentiation","volume":"123","author":"Kawakami","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0054","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1038\/s41379-019-0269-x","article-title":"JAK2\/PD-L1\/PD-L2 (9p24.1) amplifications in renal cell carcinomas with sarcomatoid transformation: implications for clinical management","volume":"32","author":"Gupta","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0055","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1158\/1078-0432.CCR-19-3283","article-title":"Comprehensive genomic analysis of translocation renal cell carcinoma reveals copy-number variations as drivers of disease progression","volume":"26","author":"Marcon","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0056","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.1158\/1078-0432.CCR-12-3825","article-title":"Genomic heterogeneity of translocation renal cell carcinoma","volume":"19","author":"Malouf","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0057","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/modpathol.2017.24","article-title":"TFEB-VEGFA (6p21.1) co-amplified renal cell carcinoma: a distinct entity with potential implications for clinical management","volume":"30","author":"Gupta","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0058","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1097\/PAS.0000000000000720","article-title":"TFEB-amplified renal cell carcinomas: an aggressive molecular subset demonstrating variable melanocytic marker expression and morphologic heterogeneity","volume":"40","author":"Argani","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0059","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/PAS.0000000000000776","article-title":"Renal cell carcinoma with chromosome 6p amplification including the TFEB gene: a novel mechanism of tumor pathogenesis?","volume":"41","author":"Williamson","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0060","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/s41379-019-0273-1","article-title":"Distinctive mechanisms underlie the loss of SMARCB1 protein expression in renal medullary carcinoma: morphologic and molecular analysis of 20 cases","volume":"32","author":"Jia","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0061","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41379-018-0185-5","article-title":"Tubulocystic renal cell carcinoma: a distinct clinicopathologic entity with a characteristic genomic profile","volume":"32","author":"Sarungbam","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0062","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1746-1596-7-21","article-title":"Synchronous clear cell renal cell carcinoma and tubulocystic carcinoma: genetic evidence of independent ontogenesis and implications of chromosomal imbalances in tumor progression","volume":"7","author":"Quiroga-Garza","year":"2012","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0063","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1097\/PAS.0000000000000719","article-title":"Tubulocystic carcinoma of the kidney with poorly differentiated foci: a frequent morphologic pattern of fumarate hydratase-deficient renal cell carcinoma","volume":"40","author":"Smith","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0064","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/PAS.0000000000000163","article-title":"Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cancer: recognition of the syndrome by pathologic features and the utility of detecting aberrant succination by immunohistochemistry","volume":"38","author":"Chen","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0065","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.humpath.2019.07.004","article-title":"Incidence of succinate dehydrogenase and fumarate hydratase-deficient renal cell carcinoma based on immunohistochemical screening with SDHA\/SDHB and FH\/2SC","volume":"91","author":"Gupta","year":"2019","journal-title":"Hum Pathol"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0066","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.6004\/jnccn.2019.0054","article-title":"NCCN guidelines insights: kidney cancer, version 2.2020","volume":"17","author":"Motzer","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0067","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1038\/bjc.2014.420","article-title":"Chromosome 9p deletion in clear cell renal cell carcinoma predicts recurrence and survival following surgery","volume":"111","author":"El-Mokadem","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0068","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.clgc.2019.09.016","article-title":"Monosomy of chromosome 9 is associated with higher grade, advanced stage, and adverse outcome in clear-cell renal cell carcinoma","volume":"18","author":"Nejati","year":"2020","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0069","doi-asserted-by":"crossref","first-page":"4696","DOI":"10.1002\/cncr.25279","article-title":"Chromosome 9p deletions identify an aggressive phenotype of clear cell renal cell carcinoma","volume":"116","author":"La Rochelle","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2021.04.042_bib0070","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s40291-019-00414-0","article-title":"A meta-analysis evaluating clinical outcomes of patients with renal cell carcinoma harboring chromosome 9P loss","volume":"23","author":"Di Nunno","year":"2019","journal-title":"Mol Diagn Ther"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143921002052?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143921002052?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:25:55Z","timestamp":1761042355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143921002052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":70,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S1078143921002052"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2021.04.042","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A contemporary guide to chromosomal copy number profiling in the diagnosis of renal cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2021.04.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}